2012-004824-39: Comparison of two different drug protocols for ovarian stimulation in women with low egg reserve undergoing first attempt of in vitro fertilization |
|
|
| Not yet recruiting | 4 | 60 | Europe | cetrotide®, Suprecur®, Powder for solution for injection, Solution for injection, Cetrotide, buserelin | UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST, Merck Serono | response to ovarian stimulation in women with reduced ovarian reserve undergoing first cycle of in vitro fertilisaion., response to in vitro fertilisation treatment in women with predicted reduced number of eggs., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
NCT05738382: Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures |
|
|
| Not yet recruiting | 2 | 240 | RoW | BG2109, Cetrorelix, Cetrorelix Acetate | Bio Genuine (Shanghai) Biotech Co., Ltd. | Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation | 06/24 | 12/24 | | |